You have read all your free articles, to continue reading subscribe to read the rest of this content.
EpiEndo Pharmaceuticals is on the rise. The company has recently secured next phase financing and been awarded several prestigious awards, and is on course to potentially change the treatment paradigm for chronic obstructive pulmonary disease. At the Swedish-American Life Science Summit (SALSS) 2Already a subscriber Login You have read all…
Visiting some of the world’s foremost laboratories in the Swedish city of Lund, President Alar Karis remarked that contributing to their development significantly broadens the horizons of Estonian science, deepens cooperation between researchers and makes new study methods available to them. â€Already a subscriber Login You have read all your…
Cinclus Pharma has completed a financing round of SEK 250 million to fund the further clinical development of X842, a clinical-stage drug candidate for the treatment of gastroesophageal reflux disease (GERD). The Fourth Swedish National Pension Fund (AP4) joined as a new major shareholder throughAlready a subscriber Login You have…
Bonnier Ventures, the venture arm of the Bonnier group, has taken the lead in the USD 1.3 million investment round in Pilloxa. Pilloxa, founded in 2015, has developed a patient centric adherence platform consisting of smart hardware, tailored smartphone apps, data visualization and analytics. TheAlready a subscriber Login You have…
